200 related articles for article (PubMed ID: 33880111)
21. Mucinous cystic neoplasms and serous cystadenomas arising in the body-tail of the pancreas: MR imaging characterization.
Manfredi R; Ventriglia A; Mantovani W; Mehrabi S; Boninsegna E; Zamboni G; Salvia R; Pozzi Mucelli R
Eur Radiol; 2015 Apr; 25(4):940-9. PubMed ID: 25417125
[TBL] [Abstract][Full Text] [Related]
22. Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor.
Kim SY; Lee JM; Kim SH; Shin KS; Kim YJ; An SK; Han CJ; Han JK; Choi BI
AJR Am J Roentgenol; 2006 Nov; 187(5):1192-8. PubMed ID: 17056905
[TBL] [Abstract][Full Text] [Related]
23. Multiparameter diagnostic model based on
Wang G; Du L; Lu X; Chen S; Bi X; Zhang M; Luan X; Xu X; Zhang Z; Xu B; Yang J
Quant Imaging Med Surg; 2023 Sep; 13(9):5653-5663. PubMed ID: 37711769
[TBL] [Abstract][Full Text] [Related]
24. CYSTIC PANCREATIC LESIONS: IMAGING VERSUS ANATOMOPATHOLOGICAL FINDINGS-HOW TO IMPROVE DIAGNOSTIC ACCURACY?
Vieira RMF; Souza Junior AS; Kerche LE
Arq Bras Cir Dig; 2023; 36():e1735. PubMed ID: 37255104
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic usefulness of FDG PET for pancreatic mass lesions.
Koyama K; Okamura T; Kawabe J; Nakata B; Chung KH; Ochi H; Yamada R
Ann Nucl Med; 2001 Jun; 15(3):217-24. PubMed ID: 11545191
[TBL] [Abstract][Full Text] [Related]
26. The Combination of
Wang G; Liu X; Chen J; Zhang F; Xu X; Wang Y; Wang R; Yao S; Zhu J; Guan Z
Contrast Media Mol Imaging; 2022; 2022():9614678. PubMed ID: 35494209
[TBL] [Abstract][Full Text] [Related]
27. Glycopatterns and Glycoproteins Changes in MCN and SCN: A Prospective Cohort Study.
Wang Y; Sun Y; Feng J; Li Z; Yu H; Ding X; Yang F; Linghu E
Biomed Res Int; 2019; 2019():2871289. PubMed ID: 31467879
[No Abstract] [Full Text] [Related]
28. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
Srinivasan N; Koh YX; Goh BKP
Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
[TBL] [Abstract][Full Text] [Related]
29. Role of endosocopic ultrasound in the diagnosis of cystic tumours of the pancreas.
Petrone MC; Arcidiacono PG
Dig Liver Dis; 2008 Nov; 40(11):847-53. PubMed ID: 18499542
[TBL] [Abstract][Full Text] [Related]
30. The differential diagnosis of pancreatic cysts by MR imaging.
Nishihara K; Kawabata A; Ueno T; Miyahara M; Hamanaka Y; Suzuki T
Hepatogastroenterology; 1996; 43(9):714-20. PubMed ID: 8799419
[TBL] [Abstract][Full Text] [Related]
31. [Cystic pancreatic tumors. Review of literature and proposal of a diagnostic-therapeutic pathway].
Capaldi M; Alessandroni L; Bertolini R; Barreca M; Campanelli A; D'Amata G; Marini P; Mancacci R; Sorgi G; Tersigni R
G Chir; 2006; 27(6-7):281-8. PubMed ID: 17062201
[TBL] [Abstract][Full Text] [Related]
32. PET-MR Imaging and MR Texture Analysis in the Diagnosis of Pancreatic Cysts: A Prospective Preliminary Study.
Cheng SH; Liu D; Hou B; Hu Y; Huo L; Xing H; Jin ZY; Xue HD
Acad Radiol; 2020 Jul; 27(7):996-1005. PubMed ID: 31606313
[TBL] [Abstract][Full Text] [Related]
33. Characterization of cystic tumors of the pancreas: CT accuracy.
Procacci C; Biasiutti C; Carbognin G; Accordini S; Bicego E; Guarise A; Spoto E; Andreis IA; De Marco R; Megibow AJ
J Comput Assist Tomogr; 1999; 23(6):906-12. PubMed ID: 10589565
[TBL] [Abstract][Full Text] [Related]
34. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis.
van der Waaij LA; van Dullemen HM; Porte RJ
Gastrointest Endosc; 2005 Sep; 62(3):383-9. PubMed ID: 16111956
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing
Chen B; Feng H; Xie J; Li C; Zhang Y; Wang S
BMC Med Imaging; 2020 Jul; 20(1):85. PubMed ID: 32711449
[TBL] [Abstract][Full Text] [Related]
36. Role of multi-modality functional imaging in differentiation between benign and malignant thyroid
Shi H; Yuan Z; Yang C; Zhang J; Liu C; Sun J; Ye X
Clin Transl Oncol; 2019 Nov; 21(11):1561-1567. PubMed ID: 30924093
[TBL] [Abstract][Full Text] [Related]
37. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
38. Preliminary evaluation of 18F-FDG-PET/MRI for differentiation of serous from nonserous pancreatic cystic neoplasms: a pilot study.
Sagheb S; Metser U; Razaz S; Menezes R; Gallinger S; Jhaveri KS
Nucl Med Commun; 2020 Dec; 41(12):1257-1264. PubMed ID: 32925829
[TBL] [Abstract][Full Text] [Related]
39. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
40. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
